MME and type 2 diabetes mellitus: Recently, Albrechtsen et al15 observed that acute administration of ARNIs in T2DM patients may not depend on the alterations of enteropancreatic hormones, and NEP inhibitors may lead to hyperglycemia due to an increment in glucagon serum levels.